TOM BACCAM: Open Payments
NPI 1134145220 · EL CAMPO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 9 payments from 5 companies in 2025. Trend: 2023 $442 · 2024 $226 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $122 |
| Amgen Inc. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Viatris Specialty LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Ozempic, OTEZLA, AIRSUPRA, YUPELRI, REXULTI.
Industry payments across TX — which companies pay providers there.
